Mar 11
|
BioVie Announces Pipeline Update and Near-Term Clinical Priorities
|
Mar 6
|
BioVie Inc. Announces Closing of Public Offering
|
Mar 4
|
BioVie Inc. Announces Pricing of Public Offering
|
Feb 6
|
BioVie to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Dec 29
|
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
|
Dec 22
|
Rail Vision and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
|
Dec 11
|
BioVie Inc. (BIVI) Loses -46.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
Sep 7
|
BioVie Hosting Virtual KOL Event on NE3107 in Alzheimer’s Disease Today, September 7, 2023
|
Jul 10
|
BioVie to Present Data Showing How NE3107 Potentially Regulates DNA Methylation of Specific Genes in a Manner Highly Correlated to Observed Improvements in Cognition and Biomarkers of Disease
|